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Employing monoclonal antibodies that identify T-
helper/inducer or T-suppressor/cytotoxic cells, we in-
vestigated the T-lymphocyte subsets in hypersensitivity 
granulomas developed after beryllium salt injection. T-
helper/inducer cells were detected at all stages of the 
lesions, including early nonspecific inflammatory le-
sions seen at 3 weeks after injection. They formed clus-
ters intermingled with the mononuclear phagocytes in 
granulomatous lesions, but were not found among the 
epithelioid cells. In contrast, T-suppressor/cytotoxic 
cells were slow to appear in the lesions and constituted 
very small numbers in mature epithelioid cell granu-
lomas of 9-11 weeks. These findings suggest that T-
helper/inducer cells may be responsible for the evolution 
of the perivascular infiltrate of mononuclear cells. Fur-
thermore, appearance ofT-helper/inducer cells without 
T-suppressor/cytotoxic cells may contribute to the de-
velopment and organization of epithelioid cells and their 
maturity in the granulomatous lesions. 
Recently, monoclonal antibodies that identify different sub-
sets of T ce lls became available and have been used to study 
distribution of helper and suppressor/cytotoxic cells in granu-
lomatous skin les ions. In sarcoidosis, large numbers ofT cells 
present around and within granu lomas were T-helper/inducer 
cell s, while T-suppressor/cytotoxic cells rarely were found [1-
3]. Similarly the predominant T cells in tube rculoid leprosy 
were shown to be helper/inducer ceJJs [4 ,5 ], although the cases 
studied by Modlin eta! [6,7] showed a helper:suppressor ratio 
of 2:1. It has been postulated that the modulation of cell 
populations in granulomatous lesions may be assisted by T -
helper /inducer cells [3]. However, the skin lesions examined so 
far have come from random biopsies of patients, and the time 
course ofT -cell subsets in evolving lesions has not been eluci-
dated. 
Beryllium salts deposited in the skin promote development 
of either a foreign-body granu loma or a hypersensitivity gran-
uloma [8,9]. The latter type of granuloma consists primarily of 
organ ized epithelioid cells, activated macrophages, and lymph-
oid ce lls, and the pathology of fuJJy developed lesions is quite 
similar to that seen in tuberculoid leprosy and sarcoidosis. The 
experimental model has therefore been used to study not only 
the cellular pathology which occurs in granulomatous lesions 
[10], but also cell kinetics and morphologic changes or mono-
nuclear cells during the process of granuloma formation [11, 12]. 
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In the present study we used monoclonal antibody probes to 
investigate T -cell subsets in hypersensitivity granulomas ap-
pearing after beryllium salt injection. Identification of both T-
helperjinducer and T-suppressor/cytotoxic cells was possible 
and we found that large numbers of helper/inducer cells are 
exclusively involved in the lesion in early, less developed stages, 
while small numbers of suppressor/cytotoxic cells appear also 
in lesions with more differentiated macrophages and epithelioid 
cells. 
MATERIALS AND METHODS 
Skin Specimen-~ 
A total of 10 b iopsies obtained from 6 volunteers who were sensitized 
with beryllium oxide were used. They were taken from t he skin sites 
with deve loping granulomas of 3-11 weeks duration after injection of 
1-10 J.Lg beryllium oxide. The specimens were quickly frozen and kept 
at -70"C until used. 
Primary Antibodies 
Monoclonal antibodies, anti -Leu-2a a nd anti-Leu-3a were purchased 
from Becton Dickinson, Mountain View, California. 
I mmu.nope roxida.se S ta.ining 
Frozen sections, 6-J.Lm thick, were cut and placed on ge latin-coated 
slides. They were fixed in cold acetone (4 "C) , washed in 0.05 M Tris-
sa line buffer, pH 7.6, and immersed in a mixture of 3% hydrogen 
peroxide and abso lute methanol (1:9, v/v) to block e ndogenous perox-
idase activity. The sections were t hen sequen t ially incubated wit h 
normal horse se rum (diluted 1:10), t he prima ry antiserum (diluted 
1:40), biotin -horse-antimouse lgG (di lu ted 1:30) (Vector Laboratories, 
Burlingame, California) and avidin-biotin-peroxidase complex (ABC 
Vectastain Kit, Vector). Tris-saline buffer was used for dilution of all 
reagents and for washing the sections after each incubation step. 
Staining of peroxidase was done wi t h 0.05 % 3,3-diaminobenzidine 
tetrahydrochloride (Sigma Chemical Co., St. Louis, Missouri) and 
0.003% hydrogen peroxide in Tris-saline buffer. Some sections were 
stained with hematoxylin-eos in for a better appra isal of the histology 
of t he granulomas since counterstaining was found to dim the intensity 
of the immune reaction product. Control sections were stained with 
primary antibody of irrelevant specificity or with the omission of t he 
link antibody. 
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RESULTS 
Histopathologically all specimens showed typical skin lesions 
that appear in individuals with hypersensitivity to beryllium 
oxide as described previously [12]. Two, 3-week-old lesions 
revealed perivascular accumulation of small to medium sized 
mononuclear cells. In 3 biopsies taken between 4-6 weeks the 
area of cell accumulation enlarged. Although there were large 
numbers of small mononuclear cells, groups of cefls with larger 
cytoplasm considered to be activated macrophages began to be 
recognized. Fully developed granulomas were seen in 5 speci-
mens of longer than 8 weeks' duration. The lesions containing 
organized granulomas consisted of large epithelioid cells, mac-
rophages, and small to medium sized mononuclear cells (Fig 
la,b). 
Regardless of the duration, all specimens showed that about 
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F IG 1. a , Organized granuloma 11 weeks a fte r beryllium inject i o ~1 . T he les ion is composed o.f_ ep it helio id ce lls, macrophages, a nd mall to 
mediu m sized mononuclear ce ll s (X 750). b, We ll -developed ep1 t he!Jo1d ce ll co re a t a h1gher magnd1cat10n (X 1600). 
F IG 2. Leu-3a- reactive helper/ inducer cell s ident ified by t he cytoplasmic r im wit h t he sta ining p roduct.. They comprise about ha lf the ce lls in 
the lesio n s . a, X 750; b, x 1600. 
F IG 3. S ma ll numbers of Leu-2a- react. ive suppressor/ cytotoxic ce ll s scat te red in 9-week {a) a nd 11-week (b) bery llium -induced gran ulomas. 
a, >< 1200; b, x 2000. 
half of t he cells present in the lesions stained with anti-Leu-
3a, indicating that t hey are T -helper/ inducer ce lls in termingled 
with cells without the marker, which are most probably t issue 
mononuclear cell s by their morphology. As granulomas develop, 
T-helpe r/ inducer cells form sheets which surround the clusters 
of macr ophages and epithelioid cells (Fig 2a,b). In contrast, T 
cells t hat reacted with the suppressor/cytotoxic (Leu-2a) mon-
oclon a l antibody were not found at all in 3-week granulomas. 
Serial sections were cut from 2 biopsies to confi rm the obser-
vation. T -suppressor cells also were not present in the skin 
lesions of 4-6 weeks' du ration, but t hey were seen in 9- to 11-
week granulomas (Fig 3a,b ). However, T-supp ressor/cytotoxic 
cell s were always present in small numbers. They were inte r-
spersed among mononuclear cells but not in the foci of orga-
ni zed epi thelioid cells. T he ratio of helper:suppressor cells in 
these mature granulomas was about 20:1. 
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DISCUSSION 
Histopathologically t he s kin sites of hypersensit ive individ-
uals at 3 wee ks after injection of bery llium oxide did not yet 
have a typical gra nulomatous reaction ; t he hi stologic features 
may be classified as non specific perivasc ular infil t ration . H ow-
ever t he immunologic probe used in t he p resen t study disclosed 
t hat in fil t rating cells are exclus ively T -helper/inducer cells in 
t hese ea rly lesions. The observatio n differs from t he population 
ofT -ce ll subsets in nongra nulomatous inflammatory infilt ra-
tion of t he s kin. T he T -helper:suppressor ratio of about 2:1 was 
found in a lopecia a reata a nd psoriasis [13-15], and lichen 
p lanus and discoid lupus e rythematosus [13,16,17]. The ap-
pearance of a n overwhelming number ofT-helper/ inducer cell s 
over T -suppressor/cytotoxic cells also was found in fully devel-
oped hype rsensit ivity gra nulomas in beryllium-injected sites as 
seen by others in sarcoidosis (1-3], t uberculo id leprosy (4,5], 
and oth er gra nuloma tous skin lesions [18,19] . 
In norma l individuals the T -helper :suppressor cell ra tio is 
a bout 2: 1 in blood a nd t he proport io n of circulating T-helper/ 
induce r cells is reduced in patien ts wi t h active sarcoidosis 
[20,21], but a high number ofT-he lper/ inducer cells was ob-
se rved in involved mediastina l lymph nodes from t hose patients 
[22]. One might speculate t hat if T -suppressor cells also appear 
early in an inflammatory lesion it may not evolve into a 
gra nul oma and will remain as a s imple delayed-hypersensit ivity 
response [23], or even bana l chronic inflammation as in pso -
riasis, lichen planus, et c. 
That T -h elper / inducer cells are found exclusively in early 
lesions may be due to antigen stimulation. Re inherz et al [24] 
demonstrated t hat a prolife rat ive response to antigen is re-
stricted to t hat subset of T cells. In a previous study us ing 
a n t ise ra to S-100 protein , we demonstrat ed a s ignificant accu-
mulation o f dendri t ic ce lls in beryllium salt-induced hype rsen-
sit iv ity gra nulomas [25]. From morphologic ch aracteristics the 
a n t igen -presen t ing cells s imulated t hose described by othe rs as 
accessory cells which stimulate mixed leukocyte reactions [26-
28]. The initia l s igna l to elicit a n immunogenic granuloma may 
take place when t he metallic antigen on a dendritic cell mem-
bra ne interacts wit h a specifi c T -helper/ induce r cell. 
T he mecha nisms by which T-helper/inducer cells evoke a 
gra nulomatous reactio n rema in to be investigated , but Hun-
ningha ke et a! [22] rep orted t hat lung T -lymphocytes from 
sarco idosis patients, but not from no rmal subjects or patients 
wit h idiopathic pulmona ry fibrosis, sec reted a c hemotactic fac-
tor for mo nocytes. M oreover, the factor was secreted in la rger 
a mounts from T cells of t he lung tha n from those in blood. A 
similar chemotactic facto r may be secreted by s kin T -helper/ 
inducer cells t hat accumulate in t he early intervals a fter beryl-
lium injection, and this attract s a subset of monocytes which 
differe nt iate into organized granulomas. 
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